Veristat Launches Business Operations in Spain and Names Dr. Montserrat Barceló to Vice...
Leading the Organic and Acquisition Growth of Veristat Operations Throughout Europe
Veristat Named a Top Patient Recruitment Company by PharmaTech Outlook
Delivering A Patient-Centric Approach to Recruitment and Retention for Clinical Trials
SOUTHBOROUGH, MA – December 7, 2020 –Veristat, a...
Veristat Expands Pharmacovigilance and Safety Services with Acquisition of Certus PV
Delivering on Customer Demand for Pharmacovigilance from Clinical Trial Conduct to Post-Marketing Support
Veristat Announces Global Cell and Gene Therapy Center of Excellence
Accelerating cell and gene therapy opportunities for patients by advancing access to knowledge and leveraging experience for sponsors to...
Veristat Launches A Flexible Virtual Clinical Trial Solution
Veristat Enhances Patient-Centricity Offering by Delivering Clinical Trials Directly to Patients
SOUTHBOROUGH, MA – September 30, 2020 – ...
Veristat Helps Antibe Therapeutics Complete Their Phase IIB Study During COVID-19
In early 2019, Veristat helped Antibe Therapeutics, a biotech company with a drug platform of game-changing therapeutics in pain and...
Veristat Strengthens Its European Presence with the Acquisition of TCTC
Increasing Its Footprint and Expanding Therapeutic Expertise to Guide Sponsors Throughout the Clinical Development Lifecycle
Veristat Strengthens Its Regulatory Expertise with the Acquisition of Catalyst Regulatory...
Expanding Its Team of Regulatory Experts to Guide Biopharmaceutical Sponsors Along the Pathway to Market Approval